BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35368847)

  • 1. Racial disparities in health insurance, triple-negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States.
    Du X
    Mol Clin Oncol; 2022 Apr; 16(4):95. PubMed ID: 35368847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
    Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
    JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.
    Zhang W; Bai Y; Sun C; Lv Z; Wang S
    Front Public Health; 2022; 10():1058722. PubMed ID: 36530732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis.
    Lorona NC; Malone KE; Li CI
    Breast Cancer Res Treat; 2021 Dec; 190(3):549-558. PubMed ID: 34651254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Contemporary Analysis of Racial and Ethnic Disparities in Diagnosis of Early-Stage Breast Cancer and Stage-Specific Survival by Molecular Subtype.
    Primm KM; Zhao H; Hernandez DC; Chang S
    Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1185-1194. PubMed ID: 35314859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013.
    Kim A; Ashman P; Ward-Peterson M; Lozano JM; Barengo NC
    PLoS One; 2017; 12(8):e0183782. PubMed ID: 28832659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
    Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
    JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence trends in triple-negative breast cancer among women in the United States from 2010 to 2019 by race/ethnicity, age and tumor stage.
    Du XL; Li Z
    Am J Cancer Res; 2023; 13(2):678-691. PubMed ID: 36895969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries.
    Kish JK; Yu M; Percy-Laurry A; Altekruse SF
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):236-43. PubMed ID: 25417237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer.
    Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
    JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry.
    Stenzel AE; Buas MF; Moysich KB
    Cancer Epidemiol; 2019 Oct; 62():101580. PubMed ID: 31400533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
    Hoskins KF; Danciu OC; Ko NY; Calip GS
    JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013.
    Shoemaker ML; White MC; Wu M; Weir HK; Romieu I
    Breast Cancer Res Treat; 2018 Jun; 169(3):595-606. PubMed ID: 29445940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in breast cancer characteristics and outcomes by race/ethnicity.
    Ooi SL; Martinez ME; Li CI
    Breast Cancer Res Treat; 2011 Jun; 127(3):729-38. PubMed ID: 21076864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and Racial Disparities in the Utilization of Anticancer, Antihypertension, and Anti-diabetes Therapies, and in Mortality in a Large Population-Based Cohort of Older Women with Breast Cancer.
    Du XL; Song L
    J Racial Ethn Health Disparities; 2023 Feb; 10(1):446-461. PubMed ID: 35040106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer incidence trends in Asian women aged 20 or older as compared to other ethnic women in the United States from 2000 to 2018 by time period, age and tumor stage.
    Du XL; Song L
    Cancer Epidemiol; 2022 Feb; 76():102076. PubMed ID: 34861613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.
    Parise C; Caggiano V
    J Breast Cancer; 2016 Jun; 19(2):112-21. PubMed ID: 27382386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry.
    Stenzel AE; Fenstermaker RA; Wiltsie LM; Moysich KB
    J Neurooncol; 2019 Aug; 144(1):43-51. PubMed ID: 31209774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.
    Ko NY; Hong S; Winn RA; Calip GS
    JAMA Oncol; 2020 Mar; 6(3):385-392. PubMed ID: 31917398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.